$Cassava Sciences (SAVA.US)$ Bullish New Article: The current treatment scenario for Dementia Associated With Alzheimer's Disease is limited, and there is a need for more effective treatments that can address the underlying mechanisms of the disease. The report highlights the unmet needs in this area, including the need for novel approaches that can overcome the limitations of existing therapies. Emerging Drug: Simufilam: Cassava Sciences
Simufilam (formerly known as PTI-125) is an investigationa...

$Cassava Sciences (SAVA.US)$ Someone Loaded Up Buying 81k shares for $2 Million .🔥 They have been shorting to buy lots of shares at lower price to position themselves better before the soon data readout.

$Cassava Sciences (SAVA.US)$ Last Night, We Witnessed SAVA 24 Hour Market trading and it was only Available on Robinhood but no other trading platforms. Is this a way for shorts to be able to cover their short position at any time that the trial results come out? With All the Naked shorting and SEC clearly being worthless and helping market manipulators with no accountability of complaints, The Shares Short amount is definitely much higher than 45%. The market unfairness of having longs wait for ...

$Cassava Sciences (SAVA.US)$SAVA still trading up now past after hours

$Cassava Sciences (SAVA.US)$ New Form 4 by Clinical Dev Officer. All the way Bullish

$Cassava Sciences (SAVA.US)$ We do need Someone better at SEC that will actually hold the naked shorting accountable. SAVA bullish

$Cassava Sciences (SAVA.US)$ 30k shares at $26.60 and 30k shares at $26.63. Someone i
s shorting to load up shares at a lower price. Market manipulators getting in at lower price for when the stock price rises up soon

$Cassava Sciences (SAVA.US)$ Cassava taps Freda Nassif as chief commercial officer as simufilam Phase 3 readout nears. 25 years of experience leading commercial companies. SAVA ready for Success!

$Cassava Sciences (SAVA.US)$Shorts have been trying to protect their greed while we are trying to protect lives of Alzheimer's patients. None of the board members Remi, Lindsay or Wang who had shares that were valued high when the stock price went up to $175 ever sold their shares. Many of them increased their positions and many institutions have also been quietly increasing their position while each of the short stock price attacks. No other drug has given this kind of safety, cognition improvem...

$Cassava Sciences (SAVA.US)$Manny's story is inspiration. 90 Years Old. SAVA has made a difference in his life and the lives of his family members to enjoy more moments. You cannot deny the impact . This is safe and needed. Thanks to Matt, Manny's Daughter, Family and Manny for showing us there is hope on the horizon.  All of those who lost their lives and didn't get proper time with their families. We hope that others in the future will benefit from SAVA and spend more quality time with their fa...